BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 15351757)

  • 1. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
    Brannigan R; Schackman BR; Falco M; Millman RB
    Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing substance abuse programs that treat adolescents.
    Mark TL; Song X; Vandivort R; Duffy S; Butler J; Coffey R; Schabert VF
    J Subst Abuse Treat; 2006 Jul; 31(1):59-65. PubMed ID: 16814011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up services after an emergency department visit for substance abuse.
    Breton AR; Taira DA; Burns E; O'Leary J; Chung RS
    Am J Manag Care; 2007 Sep; 13(9):497-505. PubMed ID: 17803363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition education is positively associated with substance abuse treatment program outcomes.
    Grant LP; Haughton B; Sachan DS
    J Am Diet Assoc; 2004 Apr; 104(4):604-10. PubMed ID: 15054346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol and drug abuse among Connecticut youth: implications for adolescent medicine and public health.
    Ungemack JA; Hartwell SW; Babor TF
    Conn Med; 1997 Sep; 61(9):577-85. PubMed ID: 9334513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training substance abuse treatment staff to care for co-occurring disorders.
    Hunter SB; Watkins KE; Wenzel S; Gilmore J; Sheehe J; Griffin B
    J Subst Abuse Treat; 2005 Apr; 28(3):239-45. PubMed ID: 15857724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locations of facilities with special programs for older substance abuse clients in the US.
    Schultz SK; Arndt S; Liesveld J
    Int J Geriatr Psychiatry; 2003 Sep; 18(9):839-43. PubMed ID: 12949852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do total smoking bans affect the recruitment and retention of adolescents in inpatient substance abuse treatment programs? A 5-year medical chart review, 2001-2005.
    Callaghan RC; Brewster JM; Johnson J; Taylor L; Beach G; Lentz T
    J Subst Abuse Treat; 2007 Oct; 33(3):279-85. PubMed ID: 17376637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse among adolescents.
    Sussman S; Skara S; Ames SL
    Subst Use Misuse; 2008; 43(12-13):1802-28. PubMed ID: 19016166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical framework for evaluating a culturally tailored adolescent substance abuse treatment programme in Molokai, Hawaii.
    Withy KM; Lee W; Renger RF
    Ethn Health; 2007 Nov; 12(5):483-96. PubMed ID: 17978945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes.
    Moggi F; Giovanoli A; Strik W; Moos BS; Moos RH
    Drug Alcohol Depend; 2007 Jan; 86(1):75-83. PubMed ID: 16782286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an instrument measuring Chinese adolescent beliefs and attitudes towards substance abuse.
    Fok MS; Tsang WY
    J Clin Nurs; 2005 Sep; 14(8):986-94. PubMed ID: 16102150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
    Rahi JS; Manaras I; Tuomainen H; Hundt GL
    Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.